PHARMACEUTICAL COMPOSITIONS WITH ENHANCED PERFORMANCE AND IMPROVED PROCESSABILITY Russian patent published in 2018 - IPC C08B13/00 C08L1/32 

Abstract RU 2656662 C2

FIELD: chemistry.

SUBSTANCE: invention relates to a polymer comprising hydroxypropyl methyl cellulose acetate succinate (HPMC-AS) wherein a percentage of a total degree of substitution (DS) of succinoyl in position C6-OH is less than or equal to 6% (C6 C3Suc, % ≤ 6%) and in position C3-OH is from 58 to 84% (58% < C3 C3Suc, % < 84%), and percentage of a total DS of acetyl in position C6-OH ranges from 33 to 51% (33% < C6 C3Ac, % < 51%) and in position C3-OH ranges from 16 to 20% (16% < C3 C3Ac, % < 20%). Invention relates to a composition for improving the efficiency and improving the processability of a medicament that comprises a medicament and a said polymer, as well as a process for the preparation of hydroxypropyl methyl cellulose acetate succinate (HPMC-AS) having a percentage of a total DS of succinoyl in position C6-OH less than or equal to 6% (C6 C3Suc, % ≤ 6%) and in position C3-OH from 58 to 84% (58% < C3 C3Suc, % < 84%), and a percentage of a total DS of acetyl, in position C6-OH of 33 to 51% (33% < C6 C3Ac, % < 51%) and in position C3-OH of 16 to 20% (16% < C3 C3Ac, % < 20%), comprising steps of (a) reacting acetic anhydride and sodium acetate with hydroxyl propyl methylcellulose to form an intermediate at a temperature in the range of from about 85 to about 115°C; (b) maintaining the temperature for a period of 30 minutes to 2.5 hours and (c) reacting succinic anhydride with the intermediate product at a temperature for a period of 2.5 to 23.5 hours to obtain HPMC-AS.

EFFECT: increasing the effectiveness of the drug and improving processability.

10 cl, 16 dwg, 11 tbl

Similar patents RU2656662C2

Title Year Author Number
THE PHARMACEUTICAL COMPOSITIONS CONTAINING pH - DEPENDENT MEDICAL PRODUCT, THE pH MODIFIER AND THE SLOWING DOWN AGENT 2006
  • Kramer Andrea
  • Ljukel' Barbara
  • Ris Angelika
  • Zipe Shtefani
RU2442574C2
AMORPHOUS (5-FLUORO-2-METHYL-3-QUINOLIN-2-YLMETHYLINDOL-1-YL)-ACETIC ACID 2012
  • Betankur Ajmester
  • Lemyu Mark
  • Tibert Rosh
RU2616000C2
GALENICAL PREPARATIONS OF ORGANIC COMPOUNDS 2010
  • Sabina Desse-Brete
  • Shtefan Khirsh
RU2535090C2
CONTROLLED RELEASE SOLID DRUG 2006
  • Bando Khiroto
  • Kurasava Takasi
RU2467740C2
CONTROLLED RELEASE SOLID PREPARATION 2006
  • Bando Khiroto
  • Kurasava Takasi
RU2496480C2
SLOW-RELEASE MATRIX PREPARATION CONTAINING BASE AGENT OR ITS SALT AND METHOD FOR MAKING THEREOF 2005
  • Ueki Josuke
  • Fudzioka Satosi
RU2390354C2
POWDERS FOR PREPARING LIQUID DOSAGE FORM 2008
  • Bart Liven Ehlvire Kolett
  • Van Gisegkhem Ehl'Ke
  • Van Den Moter Gi Rene Jaak
  • Van Remortere Peter Jozef Marija
RU2477133C2
FLUOXETINE ENTEROSOLUBLE GRANULES, COMPOSITION, GELATIN CAPSULE, METHOD OF TREATMENT OF HUMANS AND METHOD OF PREPARING FLUOXETHINE-CONTAINING ENTEROSOLUBLE CAPSULE 1998
  • Nejl Robert Anderson
  • Rodzher Garrik Kharrison
  • Dehniel Frederik Linch
  • Piter Llojd Oren
RU2164405C2
SOLID DISPERSIONS, CONTAINING KINASE INHIBITORS 2011
  • Miller Dzhonatan
  • Gokkhale Radzhiv
  • Shmitt Ehrik A.
  • Gao I.
  • Lafunten Dzhastin
  • Dias Llojd
RU2566716C2
PHARMACEUTICAL COMPOSITIONS 2005
  • Merfi Maura
  • Dajnkhart Kirk
  • Kherter Patrisija
  • Konnelli Patrik
  • Tsuj Jun
RU2373923C2

RU 2 656 662 C2

Authors

Bryugel Todd A.

Ngujen Tujen T.

Zakhu Sangrama

Tevari Divya

Zon Yuda

Dates

2018-06-06Published

2014-02-21Filed